Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.
Tin KyawKarlheinz PeterYi LiPeter TippingBan-Hock TohAlex BobikPublished in: British journal of pharmacology (2017)
This article is part of a themed section on Targeting Inflammation to Reduce Cardiovascular Disease Risk. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.22/issuetoc and http://onlinelibrary.wiley.com/doi/10.1111/bcp.v82.4/issuetoc.